Recipharm AB: Invitation to presentation of Recipharm’s interim report for the first quarter 2016 on the 28th April

Regulatory News:

Recipharm will publish its interim report for January-March 2016 on 28 April at 07:45 am CET.

The company invites investors, analysts and media to a web conference (in English) on 28 April at 10:00 am CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the report as well as answer questions.

The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 07:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 28 April. To participate in the web conference, please use the below link: http://edge.media-server.com/m/p/a7pkzj8w

Questions may be submitted by dialing below telephone numbers or by typing them in the Q&A box during the conference. If you don’t wish to ask questions by telephone you only need to participate through the link above.

From Sweden: + 46 8 505 963 06 F

rom Denmark: + 45 354 45597

From Finland: + 358 9 8171 0317

From France: + 33 29092 0977

From Germany: + 49 30 211 510 067

From India: + 91 226187 51 03

From Italy: + 39 2 3604 67 98

From Norway: + 47 235 00 559

From Portugal: + 35 210 609104

From Spain: + 34 911 143 608

From Switzerland: + 41 44 5800083

From the UK: + 44 203 139 48 30

From the USA: + 1 718 873 90 77

Pin code for participants:

38308984#

For questions about participation in the event, please contact: Linda Holmström, Brand & Communications Manager, + 46 8 602 45 13, linda.holmstrom@recipharm.com

Recipharm AB (publ)

Corporate identity number 556498-8425

Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03

www.recipharm.com

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160426006028/en/